Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 364,111,040
  • Shares Outstanding, K 2,406,073
  • Annual Sales, $ 88,821 M
  • Annual Income, $ 14,066 M
  • EBIT $ 24,004 M
  • EBITDA $ 31,343 M
  • 60-Month Beta 0.42
  • Price/Sales 4.05
  • Price/Cash Flow 11.40
  • Price/Book 4.61

Options Overview Details

View History
  • Implied Volatility 19.89% ( +1.32%)
  • Historical Volatility 24.09%
  • IV Percentile 82%
  • IV Rank 32.15%
  • IV High 35.15% on 04/08/25
  • IV Low 12.65% on 02/12/25
  • Put/Call Vol Ratio 0.42
  • Today's Volume 29,480
  • Volume Avg (30-Day) 33,830
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 498,664
  • Open Int (30-Day) 471,473

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 2.65
  • Number of Estimates 7
  • High Estimate 2.76
  • Low Estimate 2.56
  • Prior Year 2.82
  • Growth Rate Est. (year over year) -6.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.12 +3.57%
on 05/14/25
159.44 -5.09%
on 04/17/25
-2.58 (-1.68%)
since 04/16/25
3-Month
141.50 +6.95%
on 04/09/25
169.99 -10.98%
on 03/04/25
-4.82 (-3.09%)
since 02/14/25
52-Week
140.68 +7.57%
on 01/10/25
169.99 -10.98%
on 03/04/25
-2.95 (-1.91%)
since 05/16/24

Most Recent Stories

More News
Meet the Warren Buffett Investment That's Gained 5,502,284% and Looks Set to Soar Even Higher

Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again.

AAPL : 211.26 (-0.09%)
BAC : 44.69 (+0.70%)
KO : 72.00 (+0.54%)
BRK.A : 770,660.00 (+1.52%)
JNJ : 151.33 (+1.15%)
BRK.B : 514.31 (+1.38%)
BRK-A : N/A (N/A)
BRK.TO : 38.36 (+1.43%)
BRK-B : N/A (N/A)
ORCL : 160.49 (+0.68%)
HD : 380.78 (+0.57%)
3 Magnificent Stocks That Are Passive Income Machines

ABT : 134.80 (+1.09%)
JNJ : 151.33 (+1.15%)
ABBV : 184.02 (+1.29%)
ISRG Stock Gains More than 8% YTD: Will the Uptrend Continue?

Shares of Intuitive Surgical ISRG seem to gain momentum after declining for more than two months. The stock has risen 9.7% in the past month after declining more than 30% from its all-time high of $616...

JNJ : 151.33 (+1.15%)
MDT : 86.44 (+0.38%)
ISRG : 563.60 (+0.59%)
The Smartest Dividend Stocks to Buy With $5,000 Right Now

SYY : 72.44 (+0.12%)
KO : 72.00 (+0.54%)
JNJ : 151.33 (+1.15%)
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Hurts Sales

Bayer AG BAYRY reported first-quarter 2025 core earnings of 66 cents per American Depositary Receipt (ADR), beating the Zacks Consensus Estimates of 63 cents. The company reported earnings of 77 cents...

BAYRY : 6.3700 (-0.78%)
AZN : 68.81 (+1.25%)
JNJ : 151.33 (+1.15%)
REGN : 594.32 (+1.59%)
TSX Up Again

Canada's main stock index opened higher on Tuesday, led by gains in technology stocks, as investors ...

JNJ : 151.33 (+1.15%)
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

For Immediate ReleaseChicago, IL – May 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

JNJ : 151.33 (+1.15%)
MRK : 76.06 (+1.68%)
LLY : 757.39 (+3.29%)
AMGN : 272.41 (+0.27%)
PFE : 22.83 (+1.02%)
RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US

Less than a month after announcing a $50 billion investment in its U.S. operations over the next five years, Swiss pharma giant Roche RHHBY has started rolling out the details of its plans.RHHBY unveiled...

JNJ : 151.33 (+1.15%)
LLY : 757.39 (+3.29%)
NVS : 109.59 (+1.04%)
RHHBY : 39.0300 (+1.64%)
Dow leaps 1,100 points and S&P 500 rallies 3.3% following a 90-day truce in the US-China trade war

U.S. stocks rallied after China and the United States announced a 90-day truce in their trade war

NVDA : 135.40 (+0.42%)
NRG : 159.20 (+2.70%)
AVGO : 228.61 (-1.73%)
BMO.TO : 143.75 (+0.07%)
$SPX : 5,958.38 (+0.70%)
JNJ : 151.33 (+1.15%)
EXPE : 166.66 (+0.27%)
ABNB : 138.00 (+0.88%)
$IUXX : 21,427.94 (+0.43%)
PFE : 22.83 (+1.02%)
DAL : 50.92 (+1.27%)
SG : 15.03 (-1.31%)
Invest in This ETF for Safety and Dividends

If your priority is to collect a good dividend and keep your portfolio safe amid all the turmoil in ...

KO : 72.00 (+0.54%)
JNJ : 151.33 (+1.15%)
ABBV : 184.02 (+1.29%)
NOBL : 102.07 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 154.43
2nd Resistance Point 152.96
1st Resistance Point 152.15
Last Price 151.33
1st Support Level 149.87
2nd Support Level 148.40
3rd Support Level 147.59

See More

52-Week High 169.99
Fibonacci 61.8% 158.79
Fibonacci 50% 155.33
Fibonacci 38.2% 151.88
Last Price 151.33
52-Week Low 140.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar